 David Bortz
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Biological | 15 | 2023 | 1783 | 2.550 |
Why?
| | Prefrontal Cortex | 5 | 2023 | 301 | 2.200 |
Why?
| | Ventral Tegmental Area | 4 | 2023 | 58 | 2.100 |
Why?
| | Dopaminergic Neurons | 4 | 2023 | 69 | 2.070 |
Why?
| | Glutamic Acid | 5 | 2017 | 246 | 1.660 |
Why?
| | Substantia Nigra | 3 | 2022 | 57 | 1.360 |
Why?
| | Mathematical Concepts | 4 | 2023 | 31 | 1.200 |
Why?
| | Klebsiella pneumoniae | 6 | 2012 | 47 | 0.950 |
Why?
| | Nonlinear Dynamics | 3 | 2023 | 88 | 0.920 |
Why?
| | Computer Simulation | 11 | 2018 | 978 | 0.740 |
Why?
| | Electrolysis | 1 | 2020 | 2 | 0.690 |
Why?
| | Models, Theoretical | 7 | 2020 | 578 | 0.690 |
Why?
| | Nucleus Accumbens | 3 | 2017 | 138 | 0.680 |
Why?
| | Methane | 1 | 2020 | 49 | 0.670 |
Why?
| | Reversal Learning | 2 | 2019 | 10 | 0.660 |
Why?
| | Dopamine | 1 | 2022 | 303 | 0.620 |
Why?
| | Septal Nuclei | 1 | 2019 | 23 | 0.620 |
Why?
| | Keratinocytes | 2 | 2021 | 249 | 0.620 |
Why?
| | Septum of Brain | 1 | 2018 | 4 | 0.580 |
Why?
| | Heat-Shock Proteins | 1 | 2018 | 143 | 0.550 |
Why?
| | Algorithms | 5 | 2023 | 1704 | 0.540 |
Why?
| | Transaminases | 1 | 2017 | 24 | 0.540 |
Why?
| | Longevity | 1 | 2018 | 165 | 0.530 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 2 | 2016 | 97 | 0.530 |
Why?
| | Software | 2 | 2023 | 665 | 0.520 |
Why?
| | N-Methylaspartate | 4 | 2018 | 40 | 0.520 |
Why?
| | Isoxazoles | 1 | 2016 | 54 | 0.510 |
Why?
| | Anilides | 1 | 2016 | 73 | 0.500 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2018 | 199 | 0.490 |
Why?
| | Rats | 6 | 2023 | 5647 | 0.490 |
Why?
| | Biofilms | 5 | 2013 | 260 | 0.490 |
Why?
| | Bacterial Adhesion | 2 | 2013 | 100 | 0.480 |
Why?
| | Choline | 1 | 2016 | 127 | 0.470 |
Why?
| | Caenorhabditis elegans | 1 | 2018 | 306 | 0.460 |
Why?
| | Rats, Wistar | 5 | 2017 | 455 | 0.460 |
Why?
| | Chondroitin Sulfates | 1 | 2014 | 32 | 0.450 |
Why?
| | Electrochemistry | 1 | 2014 | 78 | 0.450 |
Why?
| | Wound Healing | 2 | 2021 | 331 | 0.450 |
Why?
| | Microspheres | 1 | 2014 | 137 | 0.440 |
Why?
| | Patient-Specific Modeling | 1 | 2014 | 41 | 0.440 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 180 | 0.430 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 840 | 0.420 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2018 | 39 | 0.410 |
Why?
| | Dictyostelium | 1 | 2012 | 10 | 0.400 |
Why?
| | Cell Movement | 2 | 2021 | 967 | 0.400 |
Why?
| | Hippocampus | 2 | 2018 | 895 | 0.400 |
Why?
| | Biophysics | 1 | 2012 | 71 | 0.390 |
Why?
| | Nicotinic Agonists | 1 | 2013 | 129 | 0.380 |
Why?
| | Kinetics | 5 | 2016 | 1670 | 0.370 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2013 | 227 | 0.370 |
Why?
| | HIV-1 | 3 | 2006 | 864 | 0.350 |
Why?
| | Receptors, Nicotinic | 1 | 2013 | 334 | 0.350 |
Why?
| | Cartilage, Articular | 1 | 2014 | 311 | 0.350 |
Why?
| | Microfluidics | 1 | 2011 | 54 | 0.340 |
Why?
| | Animals | 15 | 2023 | 36940 | 0.340 |
Why?
| | Precision Medicine | 1 | 2014 | 429 | 0.330 |
Why?
| | Mechanotransduction, Cellular | 1 | 2011 | 111 | 0.320 |
Why?
| | Systems Biology | 2 | 2023 | 67 | 0.310 |
Why?
| | Polyethylene Glycols | 1 | 2014 | 641 | 0.310 |
Why?
| | Cyanobacteria | 2 | 2020 | 56 | 0.310 |
Why?
| | Movement | 1 | 2011 | 278 | 0.300 |
Why?
| | HIV Infections | 5 | 2006 | 2836 | 0.290 |
Why?
| | Signal Transduction | 3 | 2018 | 5079 | 0.290 |
Why?
| | Flocculation | 3 | 2013 | 7 | 0.270 |
Why?
| | Staphylococcus epidermidis | 3 | 2013 | 77 | 0.270 |
Why?
| | Neural Pathways | 2 | 2019 | 295 | 0.260 |
Why?
| | HIV | 2 | 2004 | 234 | 0.250 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2006 | 84 | 0.250 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1040 | 0.240 |
Why?
| | Kynurenine | 2 | 2017 | 114 | 0.230 |
Why?
| | Population Dynamics | 2 | 2017 | 151 | 0.220 |
Why?
| | Blood Glucose | 1 | 2014 | 2186 | 0.220 |
Why?
| | Pars Compacta | 1 | 2023 | 4 | 0.210 |
Why?
| | Elasticity | 2 | 2014 | 197 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2486 | 0.200 |
Why?
| | Complement C5a | 2 | 2013 | 71 | 0.200 |
Why?
| | Hydrodynamics | 2 | 2013 | 45 | 0.200 |
Why?
| | Numerical Analysis, Computer-Assisted | 3 | 2014 | 19 | 0.200 |
Why?
| | Bicuculline | 1 | 2022 | 23 | 0.200 |
Why?
| | Scopolamine Derivatives | 1 | 2022 | 7 | 0.200 |
Why?
| | Models, Statistical | 1 | 2006 | 669 | 0.190 |
Why?
| | Bacteremia | 4 | 2013 | 214 | 0.190 |
Why?
| | Adherens Junctions | 1 | 2021 | 25 | 0.190 |
Why?
| | Ligands | 2 | 2014 | 664 | 0.180 |
Why?
| | Cognition | 2 | 2023 | 1153 | 0.180 |
Why?
| | Bioreactors | 1 | 2020 | 42 | 0.170 |
Why?
| | Hydrogen | 1 | 2020 | 70 | 0.170 |
Why?
| | Male | 8 | 2023 | 67762 | 0.170 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 62 | 0.170 |
Why?
| | Kynurenic Acid | 2 | 2017 | 20 | 0.160 |
Why?
| | Communicable Disease Control | 1 | 2020 | 82 | 0.160 |
Why?
| | Photosynthesis | 1 | 2020 | 104 | 0.150 |
Why?
| | Peptide Hormones | 1 | 2018 | 11 | 0.150 |
Why?
| | Receptor, Insulin | 1 | 2018 | 105 | 0.140 |
Why?
| | Amphetamine | 1 | 2018 | 35 | 0.140 |
Why?
| | Globus Pallidus | 1 | 2018 | 26 | 0.140 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2018 | 59 | 0.140 |
Why?
| | Heat-Shock Response | 1 | 2018 | 77 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 187 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 240 | 0.140 |
Why?
| | Microdialysis | 1 | 2017 | 52 | 0.140 |
Why?
| | Drug Administration Routes | 1 | 2017 | 38 | 0.140 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2017 | 32 | 0.130 |
Why?
| | Electrodes | 1 | 2017 | 114 | 0.130 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 382 | 0.130 |
Why?
| | alpha Catenin | 1 | 2016 | 11 | 0.130 |
Why?
| | Central Nervous System Stimulants | 1 | 2018 | 161 | 0.130 |
Why?
| | Allosteric Regulation | 1 | 2016 | 97 | 0.130 |
Why?
| | Time Factors | 4 | 2016 | 6828 | 0.130 |
Why?
| | Thiazolidinediones | 1 | 2017 | 137 | 0.130 |
Why?
| | Bacterial Proteins | 2 | 2020 | 879 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 97 | 0.120 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 177 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Biochemical Phenomena | 1 | 2015 | 10 | 0.120 |
Why?
| | Probability | 2 | 2014 | 304 | 0.120 |
Why?
| | Pandemics | 2 | 2021 | 1639 | 0.120 |
Why?
| | Adhesiveness | 1 | 2014 | 20 | 0.110 |
Why?
| | Salts | 1 | 2014 | 37 | 0.110 |
Why?
| | Exocytosis | 1 | 2015 | 89 | 0.110 |
Why?
| | Administration, Oral | 1 | 2017 | 816 | 0.110 |
Why?
| | Cell Adhesion | 1 | 2016 | 466 | 0.110 |
Why?
| | Sulfates | 1 | 2014 | 50 | 0.110 |
Why?
| | Osmolar Concentration | 1 | 2014 | 171 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 118 | 0.110 |
Why?
| | Gels | 1 | 2014 | 80 | 0.110 |
Why?
| | Sodium Channel Blockers | 1 | 2014 | 24 | 0.110 |
Why?
| | Calibration | 1 | 2014 | 146 | 0.110 |
Why?
| | Solvents | 1 | 2014 | 109 | 0.110 |
Why?
| | Diffusion | 1 | 2014 | 116 | 0.110 |
Why?
| | Tetrodotoxin | 1 | 2014 | 39 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.110 |
Why?
| | Solutions | 1 | 2014 | 168 | 0.110 |
Why?
| | Microelectrodes | 1 | 2014 | 45 | 0.110 |
Why?
| | Analysis of Variance | 1 | 2017 | 1316 | 0.110 |
Why?
| | Biological Clocks | 1 | 2014 | 45 | 0.110 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 48 | 0.110 |
Why?
| | Insulin | 2 | 2015 | 2409 | 0.110 |
Why?
| | Bacteria | 1 | 2020 | 858 | 0.110 |
Why?
| | Catheters, Indwelling | 1 | 2014 | 91 | 0.100 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 217 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2014 | 109 | 0.100 |
Why?
| | Staphylococcal Infections | 3 | 2013 | 400 | 0.100 |
Why?
| | Biological Evolution | 1 | 2017 | 474 | 0.100 |
Why?
| | Virus Replication | 3 | 2004 | 483 | 0.100 |
Why?
| | Schizophrenia | 2 | 2014 | 439 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 560 | 0.100 |
Why?
| | Motor Activity | 1 | 2018 | 718 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 623 | 0.100 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2013 | 61 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2016 | 614 | 0.100 |
Why?
| | Internet | 1 | 2017 | 655 | 0.100 |
Why?
| | Animal Distribution | 1 | 2012 | 24 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2057 | 0.100 |
Why?
| | Moths | 1 | 2012 | 45 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2014 | 844 | 0.090 |
Why?
| | Water | 1 | 2014 | 460 | 0.090 |
Why?
| | Bacterial Capsules | 1 | 2011 | 30 | 0.090 |
Why?
| | Drug Resistance, Bacterial | 1 | 2012 | 186 | 0.090 |
Why?
| | Polymers | 1 | 2014 | 490 | 0.080 |
Why?
| | Cell Count | 1 | 2011 | 324 | 0.080 |
Why?
| | Humans | 14 | 2021 | 137585 | 0.080 |
Why?
| | Metformin | 1 | 2014 | 331 | 0.080 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 377 | 0.080 |
Why?
| | Cell Line | 1 | 2016 | 2847 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2013 | 828 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2014 | 4295 | 0.080 |
Why?
| | Microbial Viability | 1 | 2009 | 91 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2607 | 0.080 |
Why?
| | Computational Biology | 1 | 2013 | 644 | 0.070 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2014 | 605 | 0.070 |
Why?
| | Aging | 1 | 2018 | 1864 | 0.070 |
Why?
| | Anti-Bacterial Agents | 3 | 2012 | 1809 | 0.070 |
Why?
| | Complement System Proteins | 1 | 2009 | 327 | 0.060 |
Why?
| | Female | 3 | 2023 | 73304 | 0.060 |
Why?
| | CD4 Lymphocyte Count | 1 | 2006 | 269 | 0.060 |
Why?
| | RNA, Viral | 2 | 2006 | 656 | 0.060 |
Why?
| | Klebsiella Infections | 1 | 2005 | 26 | 0.060 |
Why?
| | Pneumonia, Bacterial | 1 | 2005 | 116 | 0.050 |
Why?
| | HIV Protease Inhibitors | 1 | 2004 | 69 | 0.050 |
Why?
| | Virus Latency | 1 | 2004 | 80 | 0.050 |
Why?
| | Viral Load | 1 | 2006 | 466 | 0.050 |
Why?
| | Principal Component Analysis | 1 | 2004 | 195 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2668 | 0.050 |
Why?
| | Phycobilisomes | 1 | 2020 | 3 | 0.040 |
Why?
| | Synechococcus | 1 | 2020 | 10 | 0.040 |
Why?
| | Carbon Cycle | 1 | 2020 | 18 | 0.040 |
Why?
| | Policy | 1 | 2021 | 150 | 0.040 |
Why?
| | Organelles | 1 | 2020 | 58 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 160 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1946 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2006 | 1996 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2021 | 620 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2020 | 267 | 0.040 |
Why?
| | Light | 1 | 2020 | 381 | 0.030 |
Why?
| | Complement C3 | 2 | 2009 | 209 | 0.030 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2014 | 40 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2014 | 65 | 0.030 |
Why?
| | Amidohydrolases | 1 | 2013 | 31 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | Polysaccharides, Bacterial | 1 | 2013 | 70 | 0.020 |
Why?
| | Equipment Contamination | 1 | 2013 | 67 | 0.020 |
Why?
| | Central Venous Catheters | 1 | 2013 | 51 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2012 | 73 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 165 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1178 | 0.020 |
Why?
| | Mice | 2 | 2008 | 17787 | 0.020 |
Why?
| | Attention | 1 | 2014 | 427 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4565 | 0.020 |
Why?
| | Trans-Activators | 1 | 2013 | 398 | 0.020 |
Why?
| | Opsonin Proteins | 1 | 2009 | 25 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 325 | 0.020 |
Why?
| | Serum | 1 | 2009 | 59 | 0.020 |
Why?
| | Complement Activation | 1 | 2013 | 415 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2009 | 76 | 0.020 |
Why?
| | Health | 1 | 2009 | 84 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 247 | 0.020 |
Why?
| | Diet | 1 | 2014 | 1278 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2014 | 2833 | 0.020 |
Why?
| | Models, Immunological | 1 | 2006 | 100 | 0.020 |
Why?
| | Serratia Infections | 1 | 2005 | 8 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2006 | 148 | 0.020 |
Why?
| | Serratia marcescens | 1 | 2005 | 16 | 0.010 |
Why?
| | Galactose | 1 | 2005 | 33 | 0.010 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2006 | 173 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2005 | 298 | 0.010 |
Why?
| | Sepsis | 1 | 2009 | 617 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 6763 | 0.010 |
Why?
| | Logistic Models | 1 | 2006 | 2074 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2006 | 1091 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 3958 | 0.010 |
Why?
| | Lung | 1 | 2005 | 4060 | 0.010 |
Why?
|
|
Bortz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|